Literature DB >> 16479139

Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.

Takuya Misugi1, Koji Ozaki, Khaled El Beltagy, Osamu Tokuyama, Ken-ichi Honda, Osamu Ishiko.   

Abstract

BACKGROUND: Insulin-lowering agents are reported to be useful in treating polycystic ovary syndrome (PCOS) anovulation. It has been suggested that lower insulin levels secondarily affect ovarian tissue, although the direct mechanism of action has not yet been verified. Here we investigated if these agents directly affect the ovary.
METHODS: Thirty female Wister rats were studied. Six control rats were injected subcutaneously with 0.2 ml sesame oil, while 24 rats used as PCOS models were injected subcutaneously with dehydroepiandrosterone (DHEA) and divided into four groups. Six rats were injected with only DHEA, while the remaining 18 rats received metformin, pioglitazone or troglitazone. The ovaries were immunohistochemically stained with anti- testosterone and anti-17beta-HSD antibodies, and then evaluated for morphological changes.
RESULTS: In the DHEA administration group, the number of atretic follicles significantly increased compared to that of control rats. The insulin-lowering agents did not improve the multicystic appearance. Serum testosterone concentrations significantly increased with DHEA administration, but the increase was inhibited by oral administration of insulin-lowering agents. Testosterone deposits in ovarian tissue were also reduced by feeding rats insulin-lowering agents.
CONCLUSION: Insulin-lowering agents affected ovarian tissue by inhibiting testosterone biosynthesis in vivo. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479139     DOI: 10.1159/000091496

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  6 in total

1.  Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats.

Authors:  Victoria Tyndall; Marie Broyde; Richard Sharpe; Michelle Welsh; Amanda J Drake; Alan S McNeilly
Journal:  Reproduction       Date:  2011-10-20       Impact factor: 3.906

Review 2.  Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.

Authors:  Larissa Paixão; Ramon B Ramos; Anita Lavarda; Debora M Morsh; Poli Mara Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2017-02-10       Impact factor: 5.211

3.  Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.

Authors:  Selenay Furat Rencber; Sema Kurnaz Ozbek; Ceyla Eraldemır; Zehra Sezer; Tugba Kum; Sureyya Ceylan; Elif Guzel
Journal:  J Ovarian Res       Date:  2018-06-29       Impact factor: 4.234

4.  Abnormal expression of HSP70 may contribute to PCOS pathology.

Authors:  Gengxiang Wu; Xue Hu; Jinli Ding; Jing Yang
Journal:  J Ovarian Res       Date:  2019-08-09       Impact factor: 4.234

5.  Short-time intensive insulin therapy upregulates 3 beta- and 17 beta-hydroxysteroid dehydrogenase levels in men with newly diagnosed T2DM.

Authors:  Yun Hu; Ying Wang; Ting-Ting Cai; Lu Liu; Dong-Mei Li; Jian-Hua Ma; Bo Ding
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

6.  Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior.

Authors:  Benedikt Gasser; Johann Kurz; Samuel Buerki; Markus Mohaupt
Journal:  Life (Basel)       Date:  2022-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.